Anavex Life Sciences Corp (AVXL)

[Biostockclub]

Good afternoon, Board.

Kindly read this and tell me if BIIB just blinked again? Addressing how they will handle “late stage, more pricey acquisitions”. (Read the last sentence from the CFO - they talked around it to be coy, then buried the lead, imo.)

The CFO mentions that they desire more of an international presence...especially AsiaPacific markets (wait, aren’t they partners with Eisai??? But Australia is AsiaPacific) and lesser European markets mentioned along with Latino market. (So, maybe Spanish speaking ones?)

He addresses MS and widening their market in the world as well - AsiaPacific. And he knows there will be competition...
Yet, when it comes to the promise of their AD drugs and trials, he politely says, (in essence), “Speak to the wife (Eisai), we have nothing to do with the decisions there.” (Very akin to the Fred McMurray in The Caine Mutiny who started the whole fiasco, then, on stand during court martial...”He never even heard of The Caine, or Captain Queeg!”)

Also, CFO mentions that “other companies” need to cut staff or sell off/ spin off divisions - (for the record, I just posted that LLY will imminently spin off their pet medication division, Elanco, in an IPO, and they reduced staff late last year and will do so again with this spin off - 5,100 jobs). Biogen did a stock repurchase when they were down to $277/sh and very recently after the AAIC when they dropped $50/sh.
CFO said they are looking to build up their value with assets for their shareholders...

Finally, lot of emphasis on stroke (big market) and the overlap with AD. Perhaps they have found a compound which will work in both indications? He mentions that the deal with Eisai was really mutually beneficial because partners can “share the cost of trials.” (Yes, if we are a pricey buyout, we can! Stroke, pain, MS, and he mentions their SMA drug is in the rare pediatric market...hmmm, is Rett a bargaining chip?)

New flash: It’s ALL a bargaining chip!!

Worth a read.
My opinion,
Bio

PAY CLOSE ATTENTION TO THE LAST SENTENCE (read it first if you wish)

Biogen, Inc. (BIIB) Presents at Morgan Stanley 16th Annual Global Healthcare Conference Transcript $BIIBhttps://seekingalpha.com/article/4205899